Authors:
LANGENBERG AG
BURKE RL
ADAIR SF
SEKULOVICH R
TIGGES M
DEKKER CL
Citation: Ag. Langenberg et al., A RECOMBINANT GLYCOPROTEIN VACCINE FOR HERPES-SIMPLEX VIRUS TYPE-2 - SAFETY AND IMMUNOGENICITY (VOL 122, PG 889, 1995), Annals of internal medicine, 123(5), 1995, pp. 395-395
Authors:
LANGENBERG AGM
BURKE RL
ADAIR SF
SEKULOVICH O
TIGGES M
DEKKER CL
COREY L
Citation: Agm. Langenberg et al., A RECOMBINANT GLYCOPROTEIN VACCINE FOR HERPES-SIMPLEX TYPE-2 - SAFETYAND EFFICACY, Annals of internal medicine, 122(12), 1995, pp. 889-898
Authors:
STRAUS SE
COREY L
BURKE RL
SAVARESE B
BARNUM G
KRAUSE PR
KOST RG
MEIER JL
SEKULOVICH R
ADAIR SF
DEKKER CL
Citation: Se. Straus et al., PLACEBO-CONTROLLED TRIAL OF VACCINATION WITH RECOMBINANT GLYCOPROTEIN-D OF HERPES-SIMPLEX VIRUS TYPE-2 FOR IMMUNOTHERAPY OF GENITAL HERPES, Lancet, 343(8911), 1994, pp. 1460-1463
Authors:
STRAUS SE
SAVARESE B
TIGGES M
FREIFELD AG
KRAUSE PR
MARGOLIS DM
MEIER JL
PAAR DP
ADAIR SF
DINA D
DEKKER C
BURKE RL
Citation: Se. Straus et al., INDUCTION AND ENHANCEMENT OF IMMUNE-RESPONSES TO HERPES-SIMPLEX VIRUSTYPE-2 IN HUMANS BY USE OF A RECOMBINATN GLYCOPROTEIN-D VACCINE, The Journal of infectious diseases, 167(5), 1993, pp. 1045-1052